Acetaminophen: Beyond pain and fever-relieving

Frontiers in Pharmacology

Volumn 2 NOV, Issue , 2011, Pages

  Blough, Eric R ^a   Wu, Miaozong ^a,b  

^a MARSHALL UNIVERSITY   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetaminophen; Antioxidant; Cardiac protection; Hyperglycemia; Skeletal muscle

Indexed keywords

GLUCOSE; INFANTS FEVERALL; INSULIN; PARACETAMOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ANALGESIC ACTIVITY; ANTIARRHYTHMIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; BRAIN INJURY; CHRONIC DRUG ADMINISTRATION; DIABETES MELLITUS; DOSE RESPONSE; DRESSLER SYNDROME; DRUG EFFICACY; DRUG METABOLISM; DRUG OVERDOSE; DRUG POTENCY; DRUG SAFETY; FEVER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; IRON OVERLOAD; LIVER TOXICITY; MUSCLE ATROPHY; MYALGIA; MYOSITIS; NEUROPROTECTION; NONHUMAN; PAIN; REPERFUSION INJURY; RHABDOMYOLYSIS;

EID: 84865991512     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2011.00072     Document Type: Article

References (54)

1. Agarwal, R., Macmillan-Crow, L. A., Rafferty, T. M., Saba, H., Roberts, D. W., Fifer, E. K., James, L. P., and Hinson, J. A. (2011). Acetaminopheninduced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. J. Pharmacol. Exp. Ther. 337, 110-116.
2. Al-Turk, W. A., and Stohs, S. J. (1981). Hepatic glutathione content and aryl hydrocarbon hydroxylase activity of acetaminophen-treated mice as a function of age. Drug Chem. Toxicol. 4, 37-48.
3. Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Standaert, M. L., Quon, M. J., Reed, B. C., Dikic, I., and Farese, R. V. (2001). Glucose activates protein kinase C-zeta/lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D: a novel mechanism for activating glucose transporter translocation. J. Biol. Chem. 276, 35537-35545.
4. Bisaglia, M., Venezia, V., Piccioli, P., Stanzione, S., Porcile, C., Russo, C., Mancini, F., Milanese, C., and Schettini, G. (2002). Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem. Int. 41, 43-54.
5. Boutaud, O., Moore, K. P., Reeder, B. J., Harry, D., Howie, A. J., Wang, S., Carney, C. K., Masterson, T. S., Amin, T., Wright, D. W., Wilson, M. T., Oates, J. A., and Roberts, L. J. II. (2010). Acetaminophen inhibits hemoproteincatalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc. Natl. Acad. Sci. U.S.A. 107, 2699-2704.
6. Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B., and Rondinone, C. M. (2003). Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634-641.
7. Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B., De Oliveira, M. G., Velloso, L. A., Curi, R., and Saad, M. J. ((2005). S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54, 959-967.
8. Chan, A. T., Manson, J. E., Albert, C. M., Chae, C. U., Rexrode, K. M., Curhan, G. C., Rimm, E. B., Willett, W. C., and Fuchs, C. S. (2006). Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 113, 1578-1587.
9. Chou, T. M., and Greenspan, P. (2002). Effect of acetaminophen on the myeloperoxidase-hydrogen peroxide-nitrite mediated oxidation of LDL. Biochim. Biophys. Acta 1581, 57-63.
10. Clark, S. J., Shojaee-Moradie, F., Croos, P., Seed, P. T., Umpleby, A. M., Wendon, J. A., and Miell, J. (2001). Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen. Hepatology 34, 109-115.
11. Dai, W.,and Kloner, R. A. (2003). Effects of acetaminophen on myocardial infarct size in rats. J. Cardiovasc. Pharmacol. Ther. 8, 277-284.
12. D'Alessandris, C., Lauro, R., Presta, I., and Sesti, G. (2007). C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 50, 840-849.
13. Dinis, T. C., Maderia, V. M., and Almeida, L. M. (1994). Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch. Biochem. Biophys. 315, 161-169.
14. DuBois, R. N., Hill, K. E., and Burk, R. F. (1983). Antioxidant effect of acetaminophen in rat liver. Biochem. Pharmacol. 32, 2621-2622.
15. Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Funaki, M., Inukai, K., Fukushima, Y., Kikuchi, M., Oka, Y., and Asano, T. (2001). MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J. Biol. Chem. 276, 19800-19806.
16. Ghosh, J., Das, J., Manna, P., and Sil, P. C. (2010). Acetaminophen induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid. Toxicology 268, 8-18.
17. Hadzimichalis, N. M., Baliga, S. S., Golfetti, R., Jaques, K. M., Firestein, B. L., and Merrill, G. F. (2007). Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway. Am. J. Physiol. Heart Circ. Physiol. 293, H3348-H3355.
18. Hale, S. L., and Kloner, R. A. (2004). Acetaminophen and experimental acute myocardial infarction. Cardiovasc. Drugs Ther. 18, 121-125.
19. Hinson, J. A., Han-Hsu, H., Mays, J. B., Holt, S. J., Mclean, P., and Ketterer, B. (1984). Acetaminophen-induced alterations in blood glucose and blood insulin levels in mice. Res. Commun. Chem. Pathol. Pharmacol. 43, 381-391.
20. Hoffmann, K. J., Streeter, A. J., Axworthy, D. B., and Baillie, T. A. (1985). Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol. Pharmacol. 27, 566-573.
21. Houmard, J. A., Weidner, M. D., Dolan, P. L., Leggett-Frazier, N., Gavigan, K. E., Hickey, M. S., Tyndall, G. L., Zheng, D., Alshami, A., and Dohm, G. L. (1995). Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 44, 555-560.
22. Izawa, Y., Yoshizumi, M., Fujita, Y., Ali, N., Kanematsu, Y., Ishizawa, K., Tsuchiya, K., Obata, T., Ebina, Y., Tomita, S., and Tamaki, T. (2005). ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Exp. Cell Res. 308, 291-299.
23. Kakarla, S. K., Fannin, J. C., Keshavarzian, S., Katta, A., Paturi, S., Nalabotu, S. K., Wu, M., Rice, K. M., Manzoor, K., Walker, E. M. Jr., and Blough, E. R. (2010). Chronic acetaminophen attenuates age-associated increases in cardiac ROS and apoptosis in the Fischer Brown Norway rat. Basic Res. Cardiol. 105, 535-544.
24. Kimball, S. R. (1999). Eukaryotic initiation factor eIF2. Int. J. Biochem. Cell Biol. 31, 25-29.
25. Leshnower, B. G., Sakamoto, H., Zeeshan, A., Parish, L. M., Hinmon, R., Plappert, T., Jackson, B. M., Gorman, J. H. III., and Gorman, R. C. (2006). Role of acetaminophen in acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 290, H2424-H2431.
26. Lores Arnaiz, S., Llesuy, S., Cutrin, J. C., and Boveris, A. (1995). Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic. Biol. Med. 19, 303-310.
27. Maharaj, D. S., Saravanan, K. S., Maharaj, H., Mohanakumar, K. P., and Daya, S. (2004). Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Neurochem. Int. 44, 355-360.
28. Maharaj, H., Maharaj, D. S., and Daya, S. (2006). Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab. Brain Dis. 21, 189-199.
29. Mauger, A. R., Jones, A. M., and Williams, C. A. (2010). Influence of acetaminophen on performance during time trial cycling. J. Appl. Physiol. 108, 98-104.
30. Merrill, G., Mcconnell, P., Vandyke, K., and Powell, S. (2001). Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am.J.Physiol. Heart Circ. Physiol. 280, H2631H2638.
31. Merrill, G. F. (2002). Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am. J. Physiol. Heart Circ. Physiol. 282, H1341-H1349.
32. Merrill, G. F., and Goldberg, E. (2001). Antioxidant properties of acetaminophen and cardioprotection. Basic Res. Cardiol. 96, 423-430.
33. Merrill, G. F., Merrill, J. H., Golfetti, R., Jaques, K. M., Hadzimichalis, N. S., Baliga, S. S., and Rork, T. H. (2007). Antiarrhythmic properties of acetaminophen in the dog. Exp. Biol. Med. (Maywood) 232, 1245-1252.
34. Merrill, G. F., Rork, T. H., Spiler, N. M., and Golfetti, R. (2004). Acetaminophen and myocardial infarction in dogs. Am. J. Physiol. Heart Circ. Physiol. 287, H1913-H1920.
35. Nam, T. G., Nara, S. J., Zagol-Ikapitte, I., Cooper, T., Valgimigli, L., Oates, J. A., Porter, N. A., Boutaud, O., and Pratt, D. A. (2009). Pyridine and pyrimidine analogs of acetaminophen as inhibitors of lipid peroxidation and cyclooxygenase and lipoxygenase catalysis. Org. Biomol. Chem. 7, 5103-5112.
36. Naziroglu, M., Uguz, A. C., Kocak, A., and Bal, R. (2009). Acetaminophen at different doses protects brain microsomal Ca2+ATPase and the antioxidant redox system in rats. J. Membr. Biol. 231, 57-64.
37. Ozsoy, M. B., and Pabuccuoglu, A. (2007). The effect of acetaminophen on oxidative modification of lowdensity lipoproteins in hypercholesterolemic rabbits. J. Clin. Biochem. Nutr. 41, 27-31.
38. Porubek, D. J., Rundgren, M., Harvison, P. J., Nelson, S. D., and Moldeus, P. (1987). Investigation of mechanisms of acetaminophen toxicity in isolated rat hepatocytes with the acetaminophen analogues 3,5dimethylacetaminophen and 2,6dimethylacetaminophen. Mol. Pharmacol. 31, 647-653.
39. Prior, M. J., Lavins, B. J., and Cooper, K. (2011). A randomized, placebo-controlled trial of acetaminophen extended release for treatment of post-marathon muscle soreness. Clin. J. Pain. PMID: 21760499. [Epub ahead of print].
40. Rork, T. H., Hadzimichalis, N. M., Kappil, M. A., and Merrill, G. F. (2006). Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium. J. Mol. Cell. Cardiol. 40, 553-561.
41. Schildknecht, S., Daiber, A., Ghisla, S., Cohen, R. A., and Bachschmid, M. M. (2008). Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite. FASEB J. 22, 215-224.
42. Shertzer, H. G., Kendig, E. L., Nasrallah, H. A., Johansson, E., and Genter, M. B. (2010). Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole. Int. J. Obes. (Lond.) 34, 970-979.
43. Shertzer, H. G., Schneider, S. N., Kendig, E. L., Clegg, D. J., D'alessio, D. A., and Genter, M. B. (2008). Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem. Pharmacol. 75, 1402-1410.
44. Trappe, T. A., Carroll, C. C., Dickinson, J. M., Lemoine, J. K., Haus, J. M., Sullivan, B. E., Lee, J. D., Jemiolo, B., Weinheimer, E. M., and Hollon, C. J. (2011). Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am.J.Physiol. Regul. Integr. Comp. Physiol. 300, R655-R662.
45. Trappe, T. A., Fluckey, J. D., White, F., Lambert, C. P., and Evans, W. J. (2001). Skeletal muscle PGF(2)(alpha) and PGE(2) in response to eccentric resistance exercise: influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metab. 86, 5067-5070.
46. Trappe, T. A., White, F., Lambert, C. P., Cesar, D., Hellerstein, M., and Evans, W. J. (2002). Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am. J. Physiol. Endocrinol. Metab. 282, E551-E556.
47. Van Dyke, K., Sacks, M., and Qazi, N. (1998). A new screening method to detect water-soluble antioxidants: acetaminophen (Tylenol) and other phenols react as antioxidants and destroy peroxynitrite-based luminol-dependent chemiluminescence. J. Biolumin. Chemilumin. 13, 339-348.
48. Walker, E. M. Jr., Epling, C. P., Parris, C., Cansino, S., Ghosh, P., Desai, D. H., Morrison, R. G., Wright, G. L., Wehner, P., Mangiarua, E. I., Walker, S. M., and Blough, E. R. (2007). Acetaminophen protects against iron-induced cardiac damage in gerbils. Ann. Clin. Lab. Sci. 37, 22-33.
49. Walker, E. M. Jr., Morrison, R. G., Dornon, L., Laurino, J. P., Walker, S. M., Studeny, M., Wehner, P. S., Rice, K. M., Wu, M., and Blough, E. R. (2009). Acetaminophen combinations protect against iron-induced cardiac damage in gerbils. Ann. Clin. Lab. Sci. 39, 378-385.
50. Wu, M., Desai, D. H., Kakarla, S. K., Katta, A., Paturi, S., Gutta, A. K., Rice, K. M., Walker, E. M. Jr., and Blough, E. R. (2009a). Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2. Diabetes Metab. Res. Rev. 25, 279-286.
51. Wu, M., Katta, A., Gadde, M. K., Liu, H., Kakarla, S. K., Fannin, J., Paturi, S., Arvapalli, R. K., Rice, K. M., Wang, Y., and Blough, E. R. (2009b). Aging-associated dysfunction of akt/protein kinase B: s-nitrosylation and acetaminophen intervention. PLoS ONE 4, e6430. doi:10.1371/journal.pone. 0006430
52. Wu, M., Falasca, M., and Blough, E. R. (2011). Akt/protein kinase B in skeletal muscle physiology and pathology. J. Cell. Physiol. 226, 29-36.
53. Wu, M., Liu, H., Fannin, J., Katta, A., Wang, Y., Arvapalli, R. K., Paturi, S., Karkala, S. K., Rice, K. M., and Blough, E. R. (2010). Acetaminophen improves protein translational signaling in aged skeletal muscle. Rejuvenation Res. 13, 571-579.
54. Yasukawa, T., Tokunaga, E., Ota, H., Sugita, H., Martyn, J. A., and Kaneki, M. (2005). S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J. Biol. Chem. 280, 7511-7518.